Thrombangiitis obliterans (Buerger's disease): still a limb threatening disease
- PMID: 9394964
Thrombangiitis obliterans (Buerger's disease): still a limb threatening disease
Abstract
A series of 29 well-documented and properly analysed patients with thrombangiitis obliterans (Buerger's disease) is presented. The diagnosis of Buerger's disease was based on following criteria: smoking history, onset before the age of 50 years, infrapopliteal arterial occlusive disease, either upper limb involvement or phlebitis migrans, absence of atherosclerotic risk factors other than smoking. In the last 10 years (1986-1996), we identified 29 patients who met these rigid criteria. There were 24 men and 5 women, aged 32.4 years at the moment of the disease first clinical symptom. The cumulative tobacco use averaged 16 pack-years for each patient. The initial symptom was limited gangrene of a toe (n = 9) or a finger (n = 2), foot claudication (n = 6), calf claudication (n = 3), rest pain (n = 3), migratory superficial phlebitis (n = 4), and Raynaud phenomenon (n = 2). Angiography and/or Doppler ultrasound revealed digital, pedal and calf artery involvement in all patients, with proximal extension in ten patients (femoropopliteal in ten, including three cases with external iliac artery involvement). Seven patients had also evidence of upper limb involvement. Histologic proof was available in only seven patients. Only nine patients completely stopped smoking. Treatment was exclusively medical in five cases. Twenty-four underwent sympathectomy (20 at lumbar, and four at thoracic level), with good immediate result in 16. In 11 patients a vascular reconstruction was done (eight femorocrural and three iliofemoral bypasses), with a patency rate of only 36% at two years. Amputation was required in 16 patients (a mean of 2.7 amputations per patient) at one or more levels: toe (n = 19), forefoot (n = 5), below knee (n = 8), above knee (n = 2), finger (n = 3). Two patients ended up with bilateral leg amputation. Overall, 23% (7/30) of the patients required major leg amputation during the course of the disease. Disease progression was moderately related to continued tobacco use. Buerger's disease still entails considerable risk of major amputation. Complete abstinence from tobacco use is crucial to expect stabilization of the process. However, in advanced stages of the disease and despite cessation of smoking recurrent episodes of ischaemia or tissue loss are not excluded.
Similar articles
-
Diagnostic criteria and treatment of Buerger's disease: a review.Int J Low Extrem Wounds. 2006 Jun;5(2):89-95. doi: 10.1177/1534734606288817. Int J Low Extrem Wounds. 2006. PMID: 16698911 Review.
-
Endovascular Treatment of Thromboangiitis Obliterans (Buerger's Disease).Vasc Endovascular Surg. 2018 Feb;52(2):124-130. doi: 10.1177/1538574417744085. Epub 2017 Dec 13. Vasc Endovascular Surg. 2018. PMID: 29237360 Review.
-
Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results.J Vasc Surg. 1998 Dec;28(6):964-73; discussion 73-5. doi: 10.1016/s0741-5214(98)70022-9. J Vasc Surg. 1998. PMID: 9845647
-
Surgical treatment of Buerger's disease.J Cardiovasc Surg (Torino). 1980 Jan-Feb;21(1):77-84. J Cardiovasc Surg (Torino). 1980. PMID: 7358786
-
Buerger's disease in the 21st century: diagnosis, clinical features, and therapy.Semin Vasc Surg. 2003 Sep;16(3):179-89. doi: 10.1016/s0895-7967(03)00023-1. Semin Vasc Surg. 2003. PMID: 12975757 Review.
Cited by
-
A 7-year experience with thoracoscopic sympathectomy for critical upper limb ischemia.World J Surg. 2006 Sep;30(9):1644-7. doi: 10.1007/s00268-005-0559-y. World J Surg. 2006. PMID: 16902742
MeSH terms
LinkOut - more resources
Miscellaneous